Terminal illness requiring palliative care, with indications for parenteral midazolam administration for symptom management (e.g., anxiety, restlessness, agitation, and dyspnea).

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

Showing 1–1 of 1 trials